ROCKET-AF

Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

Stadium: klaar
Middel: rivaroxaban vs warfarine
Populatie: Ritme
Fase: III
First Patient In: 15 november 2007
Last Patient In: -
Last Patient Last Visit: -

Studiedirecteur

dr. T. Lenderink

Cardioloog